COM:ORCHARD-TX
Orchard Therapeutics
- Stock
Last Close
16.65
23/01 21:00
Market Cap
380.11M
Beta: -
Volume Today
372.35K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 332.50K - | 1.34M 303.16% | 2.71M 102.01% | |||||
average payables | 2.29M - | 11.01M 379.76% | 15.05M 36.76% | 10.40M 30.89% | 9.42M 9.50% | 9.66M 2.63% | ||
average receivables | 640K - | 6.99M 992.58% | 14.56M 108.18% | 17.30M 18.84% | 25.21M 45.75% | 23.31M 7.56% | ||
book value per share | -16.37 - | 85.58 622.91% | 138.01 61.25% | 32.09 76.75% | 17.94 44.08% | 16.94 5.61% | 7.66 54.75% | |
capex per share | -0.19 - | -1.54 720.53% | -1.79 15.74% | -0.47 73.79% | -1.27 171.98% | -0.26 79.51% | -0.51 94.69% | |
capex to depreciation | -31.67 - | -5.16 83.70% | -3.36 34.86% | -2.61 22.47% | -6.32 142.46% | -1.39 78.01% | -2.38 70.95% | |
capex to operating cash flow | 0.01 - | 0.05 267.89% | 0.04 13.86% | 0.03 36.41% | 0.10 281.65% | 0.03 74.22% | 0.09 231.50% | |
capex to revenue | -1.94 - | -1.74 10.53% | -4.88 180.92% | -6.70 37.20% | -0.93 86.08% | |||
cash per share | 3.46 - | 89.00 2,469.52% | 148.87 67.27% | 34.86 76.59% | 19.30 44.62% | 17.76 8.01% | 11.21 36.85% | |
days of inventory on hand | 283.23 - | 3.26K 1,049.59% | 510.07 84.33% | |||||
days payables outstanding | 15.68K - | 5.43K 65.34% | 3.76K 30.84% | 16.16K 330.13% | 1.40K 91.35% | |||
days sales outstanding | 2.24K - | 2.38K 6.20% | 2.56K 7.76% | 24.34K 849.49% | 752.83 96.91% | |||
debt to assets | 0.11 - | 0.21 80.07% | 0.18 10.89% | 0.27 43.83% | ||||
debt to equity | 0.15 - | 0.33 112.44% | 0.28 13.09% | 0.59 108.65% | ||||
dividend yield | ||||||||
earnings yield | -0.14 - | -0.28 108.25% | -0.65 131.00% | -0.13 80.38% | -0.35 177.53% | -0.22 37.21% | -0.17 25.19% | |
enterprise value | 137.85M - | 51.49M 62.65% | 19.02M 63.07% | 1.31B 6,783.51% | 432.64M 66.95% | 167.21M 61.35% | 37.10M 77.81% | |
enterprise value over ebitda | -7.18 - | -1.35 81.23% | -0.08 94.00% | -7.98 9,757.41% | -2.92 63.44% | -4.70 61.35% | -4.59 2.38% | |
ev to operating cash flow | -9.46 - | -1.58 83.25% | -0.19 87.70% | -7.88 3,941.33% | -3.43 56.51% | -1.34 60.99% | -0.49 63.47% | |
ev to sales | 9.16 - | 520.86 5,586.49% | 166.72 67.99% | 346.18 107.64% | 5.31 98.47% | |||
free cash flow per share | -14.62 - | -33.72 130.73% | -45.02 33.51% | -18.29 59.39% | -13.97 23.59% | -10.35 25.90% | -6.43 37.84% | |
free cash flow yield | -0.10 - | -0.24 130.73% | -0.29 18.82% | -0.13 53.54% | -0.32 143.19% | -0.78 142.50% | -1.74 121.75% | |
graham net net | -17.12 - | 79.14 562.26% | 128.86 62.81% | 25.44 80.26% | 10.40 59.11% | 10.71 2.99% | 2.78 74.07% | |
graham number | 83.44 - | 275.33 229.99% | 563.26 104.58% | 112.49 80.03% | 78.55 30.17% | 33.43 57.44% | 10.30 69.20% | |
income quality | 0.76 - | 0.82 7.10% | 0.42 48.23% | 1.02 140.24% | 0.83 18.27% | 0.87 4.13% | 0.50 41.71% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0.01 Infinity% | 0.02 26.37% | |
interest coverage | -112.40 - | -67.43 40.01% | -53.32 20.93% | -33.86 36.49% | ||||
interest debt per share | 5.09 - | 6.08 19.54% | 4.85 20.21% | 4.60 5.15% | ||||
inventory turnover | 1.29 - | 0.11 91.30% | 0.72 538.33% | |||||
invested capital | 0.15 - | 0.33 112.44% | 0.28 13.09% | 0.59 108.65% | ||||
market cap | 141.34M - | 141.34M 0% | 354.86M 151.06% | 1.28B 261.29% | 429.61M 66.49% | 163.63M 61.91% | 47.44M 71.01% | |
net current asset value | -16.83M - | 83.33M 595.17% | 300.81M 260.98% | 249.81M 16.96% | 121.03M 51.55% | 162.86M 34.56% | 47.50M 70.83% | |
net debt to ebitda | 0.18 - | 2.35 1,190.95% | 1.43 39.24% | -0.16 111.45% | -0.02 87.51% | -0.10 391.98% | 1.28 1,372.35% | |
net income per share | -18.90 - | -39.37 108.25% | -102.17 159.54% | -17.53 82.85% | -15.28 12.81% | -2.93 80.81% | -0.61 79.03% | |
operating cash flow per share | -14.43 - | -32.18 123.03% | -43.24 34.36% | -17.82 58.79% | -12.70 28.73% | -10.09 20.53% | -5.93 41.27% | |
payables turnover | 0.02 - | 0.07 188.51% | 0.10 44.60% | 0.02 76.75% | 0.26 1,056.27% | |||
receivables turnover | 0.16 - | 0.15 5.84% | 0.14 7.20% | 0.01 89.47% | 0.48 3,132.54% | |||
research and ddevelopement to revenue | 98.90 - | 46.70 52.78% | 36.12 22.66% | 48.34 33.82% | 3.66 92.43% | |||
return on tangible assets | -4.46 - | -0.41 90.83% | -0.63 54.15% | -0.41 35.00% | -0.54 32.17% | -0.11 78.89% | -0.04 67.95% | |
revenue per share | 0.92 - | 0.27 70.71% | 0.26 3.18% | 0.04 85.07% | 0.54 1,298.46% | |||
roe | 1.15 - | -0.46 139.82% | -0.74 60.95% | -0.55 26.22% | -0.85 55.94% | -0.17 79.67% | -0.08 53.66% | |
roic | 1.16 - | -0.45 138.36% | -0.76 69.86% | -0.47 38.59% | -0.58 24.43% | -0.12 78.69% | -0.15 23.00% | |
sales general and administrative to revenue | 19.56 - | 21.92 12.08% | 102.79 368.83% | 6.39 93.78% | ||||
shareholders equity per share | -16.37 - | 85.58 622.91% | 138.01 61.25% | 32.09 76.75% | 17.94 44.08% | 16.94 5.61% | 7.66 54.75% | |
stock based compensation to revenue | 3.26 - | 7.73 137.16% | 10.78 39.41% | 46.66 333.01% | 2.29 95.09% | |||
tangible asset value | -16.52M - | 86.41M 622.91% | 311.34M 260.32% | 299.19M 3.90% | 178.43M 40.36% | 205.80M 15.34% | 94.70M 53.98% | |
tangible book value per share | -16.37 - | 85.58 622.91% | 138.01 61.25% | 32.09 76.75% | 17.94 44.08% | 16.60 7.47% | 7.39 55.51% | |
working capital | 163K - | 83.47M 51,106.13% | 307.61M 268.55% | 294.04M 4.41% | 171.97M 41.51% | 232.53M 35.21% | 107.58M 53.74% |
All numbers in (except ratios and percentages)